Semaglutide and slimming
Conceived, researched and already used as a drug against diabetes, Semaglutide is literally flying off the shelves halfway around the world because of its rapid and significant slimming effect, noted in its use first and foremost by influencers and celebrities who extol its extraordinary slimming effects with posts on various social networks, such as Facebook, Intagram or Tik Tok. It would appear that it has also been used by Elon Musk, now visibly slimmed down.
Semaglutide is so popular that it has become virtually unobtainable in some pharmacies. The drug, which is administered by means of one injection per week, is a compound similar to hormones naturally present in the body, called glucagon like peptide 1 (GLP1), and would appear to regularise the metabolism, acting on the main causes of obesity by reducing the urge to eat and increasing the sense of satiety, thus leading to a reduction in calorie intake.
Semaglutide and slimming, scientific studies
Marketed by Novo Nordisk, Semaglutide as an anti-obesity treatment was the subject of a study in the New England Journal of Medicine that demonstrated the drug’s ability to bring about a reduction of up to 20 per cent in baseline body weight. Another study published in Nature Medicine also confirmed the combination of Semaglutide and slimming in the long term.
In the STEP5 study, researchers confirmed Semaglutide’s efficacy in reducing body weight, which is almost three times that of the ‘old’ obesity drugs, and demonstrated in a 2-year follow-up that its efficacy is long-lasting. In Italy, the drug has already been approved.
Semaglutide and slimming, competitors
On the wave of this commercial success, other multinationals are investing in new drugs that have the same or even better effects as Semaglutide and slimming. The American pharmaceutical company Eli Lilly, for example, presented the antidiabetic drug Tirzepatide which, already approved in the USA by the Food and drug administration (Fda), would seem to be able to produce record weight loss, even comparable to surgery. An effect demonstrated by a study in the New England Journal of Medicine where the drug Tirzepatide appears to have reduced body weight by up to 20 per cent, even an average of more than the effect of Semaglutide.
But even younger companies, such as SirtLife, have recently shown in a study published in Cells how their products are able to help prevent certain cellular processes associated with obesity, mainly by transforming ‘bad fat‘ into ‘good fat‘, i.e. fat that burns calories instead of storing them.
SIRT500 Plus is in fact a potent mix of natural sirtuin-activating ingredients, in particular pterostilbene, polytadine and onochiol, capable of replicating the beneficial effects of exercise on health by activating the so-called ‘longevity genes‘, while Sirtlife LIPO, a metabolism accelerator, rich in minerals and premium polyphenols, is able to promote healthy slimming by acting on the biological factors that promote fat accumulation.
Editorial Staff SIRT500 – The Fountain of Youth